Limited role for transforming growth factor–β pathway activation-mediated escape from VEGF inhibition in murine glioma models
Author(s) -
Davide Mangani,
Michael Weller,
Emad Seyed Sadr,
Edith Willscher,
Katharina Seystahl,
Guido Reifenberger,
Ghazaleh Tabatabai,
Hans Binder,
Hannah Schneider
Publication year - 2016
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/now112
Subject(s) - angiogenesis , cancer research , glioma , vascular endothelial growth factor , transforming growth factor , biology , in vivo , transforming growth factor beta , vascular endothelial growth factor a , signal transduction , immune system , immunology , microbiology and biotechnology , vegf receptors
The vascular endothelial growth factor (VEGF) and transforming growth factor (TGF)-β pathways regulate key biological features of glioblastoma. Here we explore whether the TGF-β pathway, which promotes angiogenesis, invasiveness, and immunosuppression, acts as an escape pathway from VEGF inhibition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom